BNP Paribas Financial Markets
BLTE

BNP Paribas Financial Markets’s Belite Bio BLTE Stock Holding History

BNP Paribas Financial Markets’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.8M Buy
57,125
+24,600
+76% +$3.77M ﹤0.01% 1721
2026
Q1 		$5.19M Buy
32,525
+30,077
+1,229% +$5.06M ﹤0.01% 1994
2025
Q4 		$392K Sell
2,448
-9,101
-79% -$1.08M ﹤0.01% 3701
2025
Q3 		$855K Buy
11,549
+8,258
+251% +$542K ﹤0.01% 3229
2025
Q2 		$190K Buy
+3,291
New +$201K ﹤0.01% 3785
2025
Q1 		– Sell
-2,450
Closed -$155K – 5404
2024
Q4 		$155K Buy
+2,450
New +$162K ﹤0.01% 3998

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets's BLTE Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Belite Bio (BLTE) stake by 76% in Q2 2026, buying an estimated $3.77M and bringing the position to 57,125 shares worth $8.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

BNP Paribas Financial Markets first reported a position in BLTE in Q4 2024 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • BNP Paribas Financial Markets held 57,125 shares of Belite Bio worth $8.8M as of Q2 2026.
  • BNP Paribas Financial Markets bought 24,600 Belite Bio shares in Q2 2026, an estimated $3.77M.
  • Belite Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1721 holding.
  • BNP Paribas Financial Markets first reported a position in Belite Bio in Q4 2024 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.